{
    "nctId": "NCT03504631",
    "briefTitle": "Genotyping and Phenotyping of CYP2D6 Breast Cancer Patients on Tamoxifen",
    "officialTitle": "Genotyping and Phenotyping of CYP2D6 as Predictor of Z-endoxifen Plasma Levels in Breast Cancer Patients on Tamoxifen Treatment",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer Female",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 117,
    "primaryOutcomeMeasure": "Genotype and phenotype of CYP2D6",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Breast cancer patients on tamoxifen treatment for at least 4 months\n\nExclusion Criteria:\n\n* Abnormalities in liver markers (AST \\>2.5 x ULN)",
    "sex": "FEMALE",
    "minimumAge": "N/A",
    "stdAges": "CHILD, ADULT, OLDER_ADULT"
}